Rock Springs Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-396,280
| Closed | -$15.2M | – | 129 |
|
|
2023
Q2 | $15.2M | Sell |
396,280
-111,232
| -22% | -$2.86M | 0.36% | 65 |
|
|
2023
Q1 | $11.7M | Hold |
507,512
| – | – | 0.28% | 73 |
|
|
2022
Q4 | $13.3M | Hold |
507,512
| – | – | 0.32% | 68 |
|
|
2022
Q3 | $9.98M | Hold |
507,512
| – | – | 0.26% | 78 |
|
|
2022
Q2 | $8.88M | Sell |
507,512
-192,837
| -28% | -$3.03M | 0.26% | 82 |
|
|
2022
Q1 | $11.5M | Sell |
700,349
-20,000
| -3% | -$272K | 0.29% | 78 |
|
|
2021
Q4 | $11.7M | Buy |
720,349
+32,200
| +5% | +$458K | 0.27% | 85 |
|
|
2021
Q3 | $8.78M | Buy |
688,149
+5,700
| +0.8% | +$75K | 0.18% | 112 |
|
|
2021
Q2 | $9.64M | Buy |
682,449
+9,400
| +1% | +$150K | 0.19% | 118 |
|
|
2021
Q1 | $10.5M | Buy |
673,049
+4,200
| +0.6% | +$68.5K | 0.23% | 111 |
|
|
2020
Q4 | $10.6M | Buy |
+668,849
| New | +$10.1M | 0.22% | 112 |
|
|
2018
Q1 | – | Sell |
-83,000
| Closed | -$3.11M | – | 161 |
|
|
2017
Q4 | $3.11M | Hold |
83,000
| – | – | 0.14% | 123 |
|
|
2017
Q3 | $4.42M | Hold |
83,000
| – | – | 0.2% | 107 |
|
|
2017
Q2 | $4.73M | Hold |
83,000
| – | – | 0.24% | 102 |
|
|
2017
Q1 | $4.46M | Hold |
83,000
| – | – | 0.26% | 93 |
|
|
2016
Q4 | $4.73M | Hold |
83,000
| – | – | 0.32% | 81 |
|
|
2016
Q3 | $5.16M | Hold |
83,000
| – | – | 0.32% | 86 |
|
|
2016
Q2 | $4.69M | Hold |
83,000
| – | – | 0.35% | 85 |
|
|
2016
Q1 | $5.32M | Hold |
83,000
| – | – | 0.45% | 74 |
|
|
2015
Q4 | $11.7M | Hold |
83,000
| – | – | 0.88% | 38 |
|
|
2015
Q3 | $8.04M | Buy |
83,000
+13,000
| +19% | +$1.55M | 0.65% | 53 |
|
|
2015
Q2 | $10.6M | Buy |
+70,000
| New | +$11.6M | 0.77% | 41 |
|
Rock Springs Capital Management's KDNY Position: Q3 2023 in Review
Rock Springs Capital Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 396,280 shares — an estimated $15.2M sold.
Rock Springs Capital Management first reported a position in KDNY in Q2 2015 and held it in 22 quarters. The position peaked at $15.2M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Rock Springs Capital Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Rock Springs Capital Management sold 396,280 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $15.2M.
- Rock Springs Capital Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 22 quarters.
- Rock Springs Capital Management's Chinook Therapeutics, Inc. Common Stock position peaked at $15.2M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Rock Springs Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.